Therefore, our current work reveals the molecular mechanisms underlying tumor-macrophage symbiosis and supports the hypothesis that targeting this LDHA-mediated symbiosis could provide clinical benefits for glioblastoma patients (Fig. 8). Here, LDHA is linked to neoplasm.